11.12.2023 08:45:16 CET | Demant A/S |
Finanskalender
Selskabsmeddelelse nr. 2023-15
11. december 2023
Finanskalender for 2024
23. januar
Frist for indlevering af emner til dagsordenen for den ordinære generalforsamling*
16. januar til 5. februar
Stilleperiode forud for offentliggørelse af Årsrapport 2023
6. februar
Årsrapport 2023
6. marts
Ordinær generalforsamling
12. marts
Kapitalmarkedsdag 2024
15. april til 5. maj
Stilleperiode forud for offentliggørelse af periodemeddelelse
6. maj
Periodemeddelelse for Q1 2024
24. juli til 13. august
Stilleperiode forud for offentliggørelse af Halvårsrapport 2024
14. august
Halvårsrapport 2024
14. oktober til 3. november
Stilleperiode forud for offentliggørelse af periodemeddelelse
4. november
Periodemeddelelse for Q3 2024
* Såfremt en aktionær ønsker et bestemt emne behandlet på den ordinære generalforsamling den 6. marts 2024, skal begæring herom indsendes skriftligt til bestyrelsen senest seks uger inden afholdelse af generalforsamlingen, således at begæringen er bestyrelsen i hænde senest den 23. januar 2024.
Yderligere information:
Mathias Holten Møller, Head of Investor Relations
Telefon +45 2924 9407
Peter Pudselykke, Investor Relations OfficerTelefon +45 2830 7638www.demant.com
Kontakter
Henrik Axel Lynge Buchter, External Communication Manager, Corporate Communication & Sustainability, +45 2264 9982, heey@demant.com
Om Demant A/S
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.
Vedhæftninger
2023-15 Finanskalender 2024.pdf
11.12.2023 08:45:16 CET | Demant A/S |
Financial Calendar
Company announcement no 2023-15
11 December 2023
Financial calendar 2024
23 January
Deadline for submission of items for the agenda of the annual general meeting*
16 January to 5 February
Quiet period prior to publication of Annual Report 2023
6 February
Annual Report 2023
6 March
Annual general meeting
12 March
Capital Markets Day 2024
15 April to 5 May
Quiet period prior to publication of Interim Management Statement
6 May
Interim Management Statement for Q1 2024
24 July to 13 August
Quiet period prior to publication of Interim Report 2024
14 August
Interim Report 2024
14 October to 3 November
Quiet period prior to publication of Interim Management Statement
4 November
Interim Management Statement for Q3 2024
* Please note that if a shareholder would like to have a specific item included in the agenda for the annual general meeting on 6 March 2024, a written proposal must be submitted to the Board of Directors no later than six weeks prior to the annual general meeting, which means that proposals must reach the Board of Directors no later than 23 January 2024.
Further information:
Mathias Holten Møller, Head of Investor Relations
Phone +45 2924 9407
Peter Pudselykke, Investor Relations OfficerPhone +45 2830 7638www.demant.com
Contacts
Henrik Axel Lynge Buchter, External Communication Manager, Corporate Communication & Sustainability, +45 2264 9982, heey@demant.com
About Demant A/S
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.
Attachments
2023-15 Financial calendar 2024.pdf
